RxDoctor Payments Data

Rodica Catrava, NP

Adult Health · Woodbury, MNNPI 1265817886

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,311 of the $2,062 with a category attached, or 63.6%. Medtronic accounts for 64.3% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $1,408, 4.3 times the $329 reported in 2023. Among adult health clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,062in general payments, 2019–2025

Across 44 payments — averaging $46.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Abbott$237
  • Boston Scientific$134
  • Edwards Lifesciences$97
  • Cvrx, Inc.$63
  • Novartis$47
  • plus $158 from 9 others

What the payments were for

  • Travel & lodging$75136%
  • Food & beverage$1,31164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,062 in reported general payments places this provider in the 90th percentile of 233 adult health providers in Minnesota.

See all adult health providers in Minnesota

Medicare billing

Part B allowed, 2024
$16,077
Medicare patients
127
Services billed
173

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$59,810
Repatha SureclickEvolocumab47$53,632
XareltoRivaroxaban26$28,034
Praluent PenAlirocumab16$17,789
BrilintaTicagrelor18$16,675
Metoprolol Succinate131$2,528
ClopidogrelClopidogrel Bisulfate102$1,449
Rosuvastatin Calcium90$1,240
Atorvastatin Calcium63$882
Potassium Chloride40$726
Furosemide74$711
Amlodipine Besylate67$622
Torsemide15$618
Lisinopril46$584
Losartan Potassium51$465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$14$16,67518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 adult health providers in Minnesota.

Other adult health in Woodbury

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →